Retatrutide 99.6% Purity — Genxell Bio PharmaceuticalCertificate of Analysis · Independent third-party lab result
- Test date
- 2026-04-13
- Testing lab
- GenxellBioPharmaceutical
- Batch / lot
- GX-2026
- Quantity
- 22.66 mg
- Endotoxins
- —
- Assay method
- —
- Label dose
- 20mg
How this result compares
This Retatrutide certificate's tested purity of 99.62% ranks higher than 22% of the 9818 Retatrutide certificates with a purity result we have catalogued (median 99.83%).
Tested 2026-04-13 by GenxellBioPharmaceutical. This test is newer than 66% of our catalogued Retatrutide certificates.
Genxell Bio Pharmaceutical has 22 certificates in our corpus, including 1 for Retatrutide at a median tested purity of 99.62%.
Test report image
Community submission
Artifact capturedSubmitted by distilled-oryx-12 +542
We have the certificate image — you can verify it loads from the upstream lab and matches the artifact shown here.
OCR text Raw extracted text
Extracted via OCR. Names, emails, phone numbers, and street addresses are auto-redacted before display.
TEST REPORT JANOSHIK E-mail: [EMAIL_REDACTED] Web: www.janoshik.com Task Number #147342 Testing ordered > 18 MAR '26 Sample received > 10 APR '26 Client [EMAIL_REDACTED] Sample Retatrutide 20mg Manufacturer GenxellBioPharmaceutical Batch GX-2026 Sample description > See picture or pictures attached. Tests requested > Assessment of a peptide vial or vials. Results > Retatrutide 22.66 mg Purity 99.618% Comments > Analysis conducted > 13 APR 2026 Signature > Verify this test at www.janoshik.com/verify/ with the following unique key D5QFY7BP4DDQ